Hemodiafiltration
ONLINE HDF can help reduce the risk of mortality
A study initiated by Fresenius Medical Care has shown that using ONLINE Hemodiafiltration (ONLINE HDF) to treat patients with chronic kidney failure can lead to a significantly lower risk of mortality compared to treatment with standard hemodialysis. The study was presented in 2005 at the European Dialysis and Transplant Association (EDTA)/ European Renal Association (ERA) Congress in Istanbul. Prior to the study, it was already known that ONLINE HDF could contribute to reducing cardiovascular complications, which account for about 50 percent of all deaths among dialysis patients. In addition, ONLINE HDF therapy has the advantage of improving the control of blood pressure and anemia, a lack of red blood cells.
During HDF, the machine removes more water from the blood than during "normal" hemodialysis. The additional liquid is continually replaced with an ultra-pure electrolyte solution. Thus, the machine exchanges a high volume of fluid during treatment and removes the liquid together with metabolic toxins from the blood. As in normal dialysis, differences in concentration between the dialysis solution and the blood are also used to filter the toxins from the blood. Overall, ONLINE HDF allows for a more efficient and gentle treatment.
More patients should benefit from ONLINE HDF in the future
In "ONLINE" HDF, the machine prepares the electrolyte solution itself. By comparison, conventional HDF treatment uses bags of infusion solution. The therapy is considered more biocompatible because the machine produces not only ultra-pure electrolyte solution but also ultra-pure dialysis solution. With Fresenius Medical Care's new 5008 therapy system, ONLINE HDF treatment is widely available for the first time. The system is easy to operate and allows for an optimized use of resources such as water and electricity.
For more information about kidney patient care, please visit the UltraCare website of Fresenius Medical Care North America.
A study initiated by Fresenius Medical Care has shown that using ONLINE Hemodiafiltration (ONLINE HDF) to treat patients with chronic kidney failure can lead to a significantly lower risk of mortality compared to treatment with standard hemodialysis. The study was presented in 2005 at the European Dialysis and Transplant Association (EDTA)/ European Renal Association (ERA) Congress in Istanbul. Prior to the study, it was already known that ONLINE HDF could contribute to reducing cardiovascular complications, which account for about 50 percent of all deaths among dialysis patients. In addition, ONLINE HDF therapy has the advantage of improving the control of blood pressure and anemia, a lack of red blood cells.
During HDF, the machine removes more water from the blood than during "normal" hemodialysis. The additional liquid is continually replaced with an ultra-pure electrolyte solution. Thus, the machine exchanges a high volume of fluid during treatment and removes the liquid together with metabolic toxins from the blood. As in normal dialysis, differences in concentration between the dialysis solution and the blood are also used to filter the toxins from the blood. Overall, ONLINE HDF allows for a more efficient and gentle treatment.
More patients should benefit from ONLINE HDF in the future
In "ONLINE" HDF, the machine prepares the electrolyte solution itself. By comparison, conventional HDF treatment uses bags of infusion solution. The therapy is considered more biocompatible because the machine produces not only ultra-pure electrolyte solution but also ultra-pure dialysis solution. With Fresenius Medical Care's new 5008 therapy system, ONLINE HDF treatment is widely available for the first time. The system is easy to operate and allows for an optimized use of resources such as water and electricity.
For more information about kidney patient care, please visit the UltraCare website of Fresenius Medical Care North America.
